Director at Jin Medical (ZJYL) submits initial SEC Form 3

Rhea-AI Filing Summary

Jin Medical International Ltd. director TONG JAMES JIAYUAN has filed an initial Form 3, which identifies him as a director of the company. The filing data provided shows no reported share holdings or transactions, with all buy, sell, and exercise share counts listed as zero.

Key Figures

Buy shares reported: 0 shares Sell shares reported: 0 shares Exercise shares reported: 0 shares +2 more

5 metrics

Buy shares reported 0 shares Form 3 transactionSummary buyShares

Sell shares reported 0 shares Form 3 transactionSummary sellShares

Exercise shares reported 0 shares Form 3 transactionSummary exerciseShares

Holding entries reported 0 entries Form 3 transactionSummary holdingEntries

Ten percent owner flag 0 Form 3 field is_ten_percent_owner for reporting person

Key Terms

Form 3, transactionSummary, derivativeSummary, is_ten_percent_owner

4 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

transactionSummary financial

""transactionSummary": { "buyCount": 0, "sellCount": 0"

derivativeSummary financial

""derivativeSummary": []"

is_ten_percent_owner regulatory

""is_ten_percent_owner": 0"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 04/27/2026 - 03:14 PM Learn about SEC filing dates

FAQ

What does the Form 3 for Jin Medical (ZJYL) show about TONG JAMES JIAYUAN?

The Form 3 identifies TONG JAMES JIAYUAN as a director of Jin Medical International Ltd.. The data excerpt shows no reported share holdings or transactions, with all buy, sell, and exercise counts recorded as zero in this snapshot.

Are there any stock purchases or sales in this Jin Medical (ZJYL) Form 3?

No, this Form 3 data shows no stock purchases or sales by the reporting person. All transaction-related counts, including buyShares, sellShares, and exerciseShares, are listed as zero in the transaction summary provided.

Does the Jin Medical (ZJYL) Form 3 indicate that the director is a ten percent owner?

The filing data flags is_ten_percent_owner: 0 for TONG JAMES JIAYUAN. This means he is reported as a director but is not categorized in this snapshot as a ten percent beneficial owner of Jin Medical International Ltd.

What does a transactionSummary of all zeros mean in this Jin Medical Form 3?

A transactionSummary with all zeros indicates no reported transactions or holdings in the provided data. Buy, sell, exercise, gift, tax withholding, and restructuring counts and share amounts are all shown as zero for this reporting person.

Are there any derivative securities reported for the Jin Medical (ZJYL) director on this Form 3?

The filing excerpt shows an empty derivativeSummary array. This means no derivative securities, such as options or warrants, are listed for the reporting person in this particular Form 3 data snapshot.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

TONG JAMES JIAYUAN

(Last) (First) (Middle)

C/O JIN MEDICAL INTERNATIONAL LTD.

NO. 33 LINGXIANG ROAD, WUJIN DISTRICT

(Street)

CHANGZHOU, JIANGSU

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Jin Medical International Ltd. [ ZJYL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ James Jiayuan Tong	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)